BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 27, 2008
View Archived Issues
New agents for arthritis and other antiinflammatory conditions reported in recent patents
Read More
Novel analgesic agents reported in recent patent literature
Read More
Recent Biovitrum patent describes novel antiobesity agents
Read More
Treanda receives FDA approval for CLL
Read More
RXR agonist NRX-4204 begins phase I trial
Read More
CHMP recommends approval of Zevalin as first-line consolidation therapy
Read More
Medicago's H5N1 vaccine protects against multiple strains of avian flu
Read More
Ceragenix and FirstPoint enter license agreement for CSA-54 in HIV
Read More
Pivotal diabetes study of mitiglinide completes enrollment
Read More
FDA clears Third Wave's InPlex molecular test for cystic fibrosis
Read More
Corcept initiates phase III trial of Corlux for the psychotic features of psychotic depression
Read More
Depomed initiates dosing in phase III clinical trial of Gabapentin GR in postherpetic neuralgia
Read More
CHMP rejects UCB's appeal over refusal of E.U. MAA for Cimzia in Crohn's disease
Read More
NanoBio reports promising results from phase II study of NB-002 for onychomycosis
Read More
FDA grants clearance to ProNAi to initiate phase I clinical trials of PNT-2258 for cancer
Read More
Acceleron and Celgene receive Hart-Scott-Rodino clearance for ACE-011 collaboration
Read More
SIGA Technologies submits EUA application to the FDA for smallpox antiviral ST-246
Read More
BioLineRx reports results from phase I/II clinical trial of BL-1040 for acute MI
Read More
Thyroid-stimulating hormone reverses ovariectomy-induced bone loss in rats
Read More
JNJ-27390467, a novel tryptase inhibitor with efficacy in models of allergic asthma
Read More
Novel CCR5 antagonist profiled at Novartis
Read More
Repligen commences phase III RG-1068 trial for pancreatic MRI imaging
Read More
FDA approves IND application for use of Davanat to treat a breast cancer patient
Read More
Presidio obtains exclusive worldwide rights to XTL's NS5A program for HCV
Read More
Sosei to temporarily halt AD-923 phase III studies in cancer breakthrough pain
Read More
First Committee on New Drugs passes AnGes' NDA for Naglazyme for MPS VI
Read More